EP1268510A4 - Methode et materiels relatifs a des polypeptides et a des polynucleotides semblables a la proteine de liaison au facteur de croissance semblable a l'insuline - Google Patents

Methode et materiels relatifs a des polypeptides et a des polynucleotides semblables a la proteine de liaison au facteur de croissance semblable a l'insuline

Info

Publication number
EP1268510A4
EP1268510A4 EP01928344A EP01928344A EP1268510A4 EP 1268510 A4 EP1268510 A4 EP 1268510A4 EP 01928344 A EP01928344 A EP 01928344A EP 01928344 A EP01928344 A EP 01928344A EP 1268510 A4 EP1268510 A4 EP 1268510A4
Authority
EP
European Patent Office
Prior art keywords
polynucleotides
insulin
polypeptides
growth factor
binding protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01928344A
Other languages
German (de)
English (en)
Other versions
EP1268510A2 (fr
Inventor
Victoria Yamazaki
Vinod Asundi
Radoje T Drmanac
Chenghua Liu
Y Tom Tang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nuvelo Inc
Original Assignee
Hyseq Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hyseq Inc filed Critical Hyseq Inc
Publication of EP1268510A2 publication Critical patent/EP1268510A2/fr
Publication of EP1268510A4 publication Critical patent/EP1268510A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4743—Insulin-like growth factor binding protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EP01928344A 2000-03-31 2001-03-30 Methode et materiels relatifs a des polypeptides et a des polynucleotides semblables a la proteine de liaison au facteur de croissance semblable a l'insuline Withdrawn EP1268510A4 (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US54021700A 2000-03-31 2000-03-31
US540217 2000-03-31
US64916700A 2000-08-23 2000-08-23
US649167 2000-08-23
US78474801A 2001-02-14 2001-02-14
US784748 2001-02-14
PCT/US2001/010462 WO2001075064A2 (fr) 2000-03-31 2001-03-30 Methode et materiels relatifs a des polypeptides et a des polynucleotides semblables a la proteine de liaison au facteur de croissance semblable a l'insuline

Publications (2)

Publication Number Publication Date
EP1268510A2 EP1268510A2 (fr) 2003-01-02
EP1268510A4 true EP1268510A4 (fr) 2003-05-28

Family

ID=27415319

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01928344A Withdrawn EP1268510A4 (fr) 2000-03-31 2001-03-30 Methode et materiels relatifs a des polypeptides et a des polynucleotides semblables a la proteine de liaison au facteur de croissance semblable a l'insuline

Country Status (5)

Country Link
EP (1) EP1268510A4 (fr)
JP (1) JP2004500120A (fr)
AU (2) AU2001255214B2 (fr)
CA (1) CA2404501A1 (fr)
WO (1) WO2001075064A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2002081515A1 (ja) * 2001-04-03 2004-07-29 協和醗酵工業株式会社 インスリン様増殖因子結合蛋白質
EP2316922B1 (fr) 2002-05-24 2013-05-22 Merck Sharp & Dohme Corp. Anticorps anti-IGFR humain neutralisant
CA2541015A1 (fr) 2003-10-03 2005-04-14 Genentech, Inc. Proteines de liaison a l'igf
EP1694850B1 (fr) 2003-11-12 2011-06-29 Schering Corporation Systeme de plasmide pour l'expression multigenique
PE20050928A1 (es) 2003-11-21 2005-11-08 Schering Corp Combinaciones terapeuticas de anticuerpo anti-igfr1
EP1828249B1 (fr) 2004-12-03 2010-12-29 Schering Corporation Biomarqueurs pour la preselection de patients pour la therapie contre le recepteur du facteur de croissance semblable a l'insuline 1

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001075067A2 (fr) * 2000-03-31 2001-10-11 Hyseq, Inc. Nouveaux acides nucleiques et polypeptides
WO2001094416A2 (fr) * 2000-06-07 2001-12-13 Curagen Corporation Nouvelles proteines et acides nucleiques qui les codent

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001075067A2 (fr) * 2000-03-31 2001-10-11 Hyseq, Inc. Nouveaux acides nucleiques et polypeptides
WO2001094416A2 (fr) * 2000-06-07 2001-12-13 Curagen Corporation Nouvelles proteines et acides nucleiques qui les codent

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] 19 December 1999 (1999-12-19), XP002236615, retrieved from EBI Database accession no. AL135785 *
DATABASE GENESEQ NCBI; *
DEDERA DA, Director of Disease Biology, Functional Genomics Department, Hyseq Inc.: Declaration of 2002-10-18 on experiments supervised. *
HWA VIVIAN ET AL: "The insulin-like growth factor-binding protein (IGFBP) superfamily", ENDOCRINE REVIEWS, BALTIMORE, MD, US, vol. 20, no. 6, December 1999 (1999-12-01), pages 761 - 787, XP002211304 *

Also Published As

Publication number Publication date
EP1268510A2 (fr) 2003-01-02
JP2004500120A (ja) 2004-01-08
WO2001075064A3 (fr) 2002-02-28
CA2404501A1 (fr) 2001-10-11
WO2001075064A2 (fr) 2001-10-11
AU2001255214B2 (en) 2006-06-08
AU5521401A (en) 2001-10-15

Similar Documents

Publication Publication Date Title
AU2001234944A8 (en) Novel nucleic acids and polypeptides
EP1325120A4 (fr) Acides nucleiques et polypeptides
EP1341804A4 (fr) Nouveaux acides nucleiques et polypeptides
AU2001287430A8 (en) Moraxella polypeptides and corresponding dna fragments and uses thereof
GB2355492B (en) Engine control during changes in cylinder AFR
EP1295939A4 (fr) Proteine de liaison de facteur de croissance insulinoide
EP1276751A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1252333A4 (fr) Procedes et substances relatifs a des polypeptides de type cd84 et a des polynucleotides
EP1268510A4 (fr) Methode et materiels relatifs a des polypeptides et a des polynucleotides semblables a la proteine de liaison au facteur de croissance semblable a l'insuline
EP1254266A4 (fr) Methodes et materiaux en rapport avec des polypeptides et de polynucleotides de type alpha-2-macroglobuline
EP1534744A4 (fr) Proteines de liaison modifiees au facteur de croissance analogue de l'insuline
EP1254246A4 (fr) Methodes et matieres concernant des polypeptides et polynucleotides similaires a alpha de facteur de croissance de transformation
GB9928950D0 (en) Binding protein
EP1341803A4 (fr) Nouveaux acides nucleiques et polypeptides
IL140931A0 (en) Methods and materials relating to novel cd39-like polypeptides
AU2001262934A1 (en) Human fgf-20 nucleic acids and polypeptides
AU3486501A (en) Methods and materials relating to alpha-2-macroglobulin-like polypeptides and polynucleotides
AU1782601A (en) Methods and compositions relating to bactericidal/permeability increasing factor-like polypeptides and polynucleotides
AU2002360460A8 (en) Methods and materials relating to novel polypeptides and polynucleotides
EP1240178A4 (fr) Procedes et substances relatifs a des polypeptides de type prothrombinase et a des polynucleotides
EP1254265A4 (fr) Methodes et materiaux concernant des polypeptides et des polynucleotides du type metallocarboxypeptidase
AU5026701A (en) A novel polypeptide - homo ribosome protein s3-12 and polynucleotide encoding said polypeptide
AU2001263005A8 (en) Novel nucleic acids and polypeptides
EP1268762A4 (fr) Nouveaux acides nucleiques et polypeptides
AU2001232967A1 (en) Methods and materials relating to novel growth regulatory-like polypeptides and polynucleotides

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20021015

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

A4 Supplementary search report drawn up and despatched

Effective date: 20030411

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NUVELO INC.

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NUVELO, INC.

17Q First examination report despatched

Effective date: 20040205

17Q First examination report despatched

Effective date: 20040205

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20080218